Texas has made a name for itself in biotech by supporting premier academic medical centers, attracting research funding and welcoming investment by major pharmaceutical companies. Now it is time to take the next step with a smart state investment in biomedical research, paving the way for Texas to become a major hub in the vibrant biotechnology industry.
Mike Collier’s TribTalk article clearly shows either his total ignorance regarding Texas law and the state budgeting process — as well as his absolute lack of qualifications for the office he seeks — or his willingness to intentionally mislead Texans about the issues facing our state.
The irony with long-term issues is they don’t need to be solved immediately, yet because they do not need to be solved immediately, those issues are rarely adequately funded in each state budget. The Texas Legacy Fund within the ESF would allow the state to better manage long-term issues, which are the greatest threat to our state’s AAA credit rating.
Texans must feel confident that their tax dollars are being used wisely and fairly. As the state's chief financial officer, I'm committed to transparency and trustworthiness in the contracting and purchasing process.
